Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GLMD
#4054
Galmed Pharmaceuticals Ltd.
0.6
1
-7.58%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-7.58%
Monthly Change
-28.24%
6 month change
-56.74%
Year Change
-72.27%
Previous Close
0.6
6
Open
0.6
1
Bid
Ask
Low
0.6
1
High
0.6
1
Volume
2
Markets
US Stock Market
Healthcare
GLMD
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
TTM
Cash from operating activities
26.29 M
32.89 M
18.5 M
6.14 M
5.88 M
-18.72 M
Cash from investing activities
16.54 M
11.46 M
17.56 M
800 K
1.11 M
—
Cash from financing activities
768 K
17.37 M
70 K
6.18 M
8.79 M
—
Free cash flow
26.24 M
32.88 M
18.5 M
6.14 M
5.88 M
-18.72 M
News
Galmed Pharmaceuticals schedules special shareholder meeting for March 4
Galmed Pharmaceuticals receives Nasdaq minimum bid price notice
Galmed to present data on Aramchol’s potential in liver cancer
Galmed stock rises after patent grant for MASH combo therapy
Galmed receives patent for combination therapy in South Korea
Galmed Pharmaceuticals stock rises on CEO’s optimistic outlook
Galmed reports $19.2 million cash position, advances Aramchol programs
Galmed stock soars after promising cancer treatment research results
Galmed reports 3-drug combo enhances cancer treatment efficacy
Galmed Pharmaceuticals schedules annual general meeting for October 28
Galmed to invest up to $10M in digital assets as part of new strategy
Galmed plans to invest up to $10 million in digital assets